Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

359 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DTG procurement guidelines in heart beating donors.
Wunderlich H, Brockmann JG, Voigt R, Rauchfuss F, Pascher A, Brose S, Binner C, Bittner H, Klar E; Commission of Organ Donation and Removal German Transplantation Society. Wunderlich H, et al. Among authors: pascher a. Transpl Int. 2011 Jul;24(7):733-57. doi: 10.1111/j.1432-2277.2011.01266.x. Transpl Int. 2011. PMID: 21668528 Free article. No abstract available.
Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial.
Guba M, Pratschke J, Hugo C, Krämer BK, Nohr-Westphal C, Brockmann J, Andrassy J, Reinke P, Pressmar K, Hakenberg O, Fischereder M, Pascher A, Illner WD, Banas B, Jauch KW; SMART-Study Group. Guba M, et al. Among authors: pascher a. Transplantation. 2010 Jul 27;90(2):175-83. doi: 10.1097/TP.0b013e3181e11798. Transplantation. 2010. PMID: 20463641 Clinical Trial.
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation.
Guba M, Pratschke J, Hugo C, Krämer BK, Pascher A, Pressmar K, Hakenberg O, Fischereder M, Brockmann J, Andrassy J, Banas B, Jauch KW; SMART-Study Group. Guba M, et al. Among authors: pascher a. Transpl Int. 2012 Apr;25(4):416-23. doi: 10.1111/j.1432-2277.2012.01432.x. Epub 2012 Feb 10. Transpl Int. 2012. PMID: 22320241 Free article.
Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation.
Sterneck M, Kaiser GM, Heyne N, Richter N, Rauchfuss F, Pascher A, Schemmer P, Fischer L, Klein CG, Nadalin S, Lehner F, Settmacher U, Neuhaus P, Gotthardt D, Loss M, Ladenburger S, Paulus EM, Mertens M, Schlitt HJ. Sterneck M, et al. Among authors: pascher a. Am J Transplant. 2014 Mar;14(3):701-10. doi: 10.1111/ajt.12615. Epub 2014 Feb 6. Am J Transplant. 2014. PMID: 24502384 Free PMC article. Clinical Trial.
Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study.
Sterneck M, Kaiser GM, Heyne N, Richter N, Rauchfuss F, Pascher A, Schemmer P, Fischer L, Klein CG, Nadalin S, Lehner F, Settmacher U, Gotthardt D, Loss M, Ladenburger S, Wimmer P, Dworak M, Schlitt HJ. Sterneck M, et al. Among authors: pascher a. Clin Transplant. 2016 Jun;30(6):741-8. doi: 10.1111/ctr.12744. Epub 2016 May 10. Clin Transplant. 2016. PMID: 27160359 Clinical Trial.
Extended Pancreas Donor Program-The EXPAND Study: A Prospective Multicenter Trial Testing the Use of Pancreas Donors Older Than 50 Years.
Proneth A, Schnitzbauer AA, Schenker P, Wunsch A, Rauchfuss F, Arbogast H, Manekeller S, Nadalin S, Heise M, Ströhlein MA, Banas B, Schemmer P, Becker T, Bechstein WO, Pascher A, Viebahn R, Geissler EK, Schlitt HJ, Farkas SA. Proneth A, et al. Among authors: pascher a. Transplantation. 2018 Aug;102(8):1330-1337. doi: 10.1097/TP.0000000000002122. Transplantation. 2018. PMID: 29406443 Clinical Trial.
ABO-Incompatible Living Donor Kidney Transplantation in a Human Immunodeficiency Virus-Positive Recipient From a Human Immunodeficiency Virus-Positive Donor: A Case Report.
Katou S, Vogel T, Morgul H, Eichelmann AK, Becker F, Slepecka P, Boehmer K, Reichelt D, Reuter S, Pascher A, Suwelack B, Brockmann J. Katou S, et al. Among authors: pascher a. Transplant Proc. 2020 Nov;52(9):2739-2741. doi: 10.1016/j.transproceed.2020.07.008. Epub 2020 Aug 6. Transplant Proc. 2020. PMID: 32771247
359 results